Pharmacokinetics/pharmacodynamics characterization of combined antimicrobial agents: a real challenge and an urgent need

被引：13
作者：
Couet, W. [1 ,2 ]
机构：
[1] Univ Poitiers, INSERM, U1070, Poitiers, France
[2] CHU Poitiers, Poitiers, France
来源：
CLINICAL MICROBIOLOGY AND INFECTION | 2018年 / 24卷 / 07期
关键词：
D O I：
10.1016/j.cmi.2018.03.047
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：687 / 688
页数：2
相关论文
共 7 条
[1]   Novel Modeling Framework To Guide Design of Optimal Dosing Strategies for β-Lactamase Inhibitors [J].
Bhagunde, Pratik ;
Chang, Kai-Tai ;
Hirsch, Elizabeth B. ;
Ledesma, Kimberly R. ;
Nikolaou, Michael ;
Tam, Vincent H. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (05) :2237-2240
[2]  
Brill MJE, 2017, CLIN MICROBIOL INFEC, V17, P30670
[3]   Pharmacokinetic/pharmacodynamic studies in the CMI [J].
Couet, W. .
CLINICAL MICROBIOLOGY AND INFECTION, 2016, 22 (10) :821-821
[4]  
Rao GG, 2017, CLIN MICROBIOL INFEC, V17, P30677
[5]  
Sy SKB, 2018, J ANTIMICROB CHEMOTH
[6]   Use of Monte Carlo simulation and considerations for PK-PD targets to support antibacterial dose selection [J].
Trang, Michael ;
Dudley, Michael N. ;
Bhavnani, Sujata M. .
CURRENT OPINION IN PHARMACOLOGY, 2017, 36 :107-113
[7]  
Ungphakorn W, 2017, CLIN MICROBIOL INFEC, V17, P30619
1